Skip to main content

Physical Activity Time, Step Counts Yield Similar Results

Medically reviewed by Carmen Pope, BPharm. Last updated on May 22, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, May 21, 2024 -- Moderate-to-vigorous physical activity (MVPA) time and step counts are similarly associated with all-cause mortality and cardiovascular disease, according to a study published online May 20 in JAMA Internal Medicine.

Rikuta Hamaya, M.D., Ph.D., from Brigham and Women’s Hospital in Boston, and colleagues examined the associations of MVPA time and step counts with all-cause mortality and cardiovascular disease among 14,399 participants in the Women’s Health Study (ages 62 years and older).

The researchers found that during a median follow-up of 9.0 years, the risk for all-cause mortality was inversely tied to MVPA time (hazard ratio, 0.82) and step counts (hazard ratio, 0.74). Similarly, greater MVPA time and step counts (top three quartiles versus bottom quartile) were associated with a longer period free from death: 2.22 and 2.36 months at nine years follow-up, respectively. For all-cause mortality, area under the receiver operating characteristic curves were similar for MVPA time and step counts (0.55 for both metrics). Similar findings were seen for cardiovascular disease.

"Step count-based goals should be considered for future guidelines along with time-based goals, allowing for the accommodation of personal preferences," the authors write.

One author disclosed ties to DeSC Healthcare.

Abstract/Full Text (subscription or payment may be required)

Editor's Note (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older

TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.